These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 16983701

  • 1. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
    Suppiah R, Shaheen PE, Elson P, Misbah SA, Wood L, Motzer RJ, Negrier S, Andresen SW, Bukowski RM.
    Cancer; 2006 Oct 15; 107(8):1793-800. PubMed ID: 16983701
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F, Kilciler M, Bedir S, Ozgok Y, Coban H, Erten K.
    Urol Int; 2007 Oct 15; 79(2):111-6. PubMed ID: 17851278
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of thrombocytosis in renal cell carcinoma.
    Bensalah K, Leray E, Fergelot P, Rioux-Leclercq N, Tostain J, Guillé F, Patard JJ.
    J Urol; 2006 Mar 15; 175(3 Pt 1):859-63. PubMed ID: 16469566
    [Abstract] [Full Text] [Related]

  • 4. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
    Ito K, Asano T, Yoshii H, Satoh A, Sumitomo M, Hayakawa M.
    Int J Urol; 2006 Nov 15; 13(11):1365-70. PubMed ID: 17083384
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of thrombocytosis in renal cell carcinoma patients.
    Inoue K, Kohashikawa K, Suzuki S, Shimada M, Yoshida H.
    Int J Urol; 2004 Jun 15; 11(6):364-7. PubMed ID: 15157203
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
    Mani S, Todd MB, Katz K, Poo WJ.
    J Urol; 1995 Jul 15; 154(1):35-40. PubMed ID: 7539867
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.
    Escudier B, Choueiri TK, Oudard S, Szczylik C, Négrier S, Ravaud A, Chevreau C, Venner P, Champagne P, Croteau D, Dupont E, Hariton C, Bukowski RM.
    J Urol; 2007 Nov 15; 178(5):1901-5. PubMed ID: 17868728
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug 15; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 10. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S, Brookman-Amissah S, Roigas J, Kendel F, Hoschke B, May M.
    Scand J Urol Nephrol; 2008 Aug 15; 42(6):507-13. PubMed ID: 19031267
    [Abstract] [Full Text] [Related]

  • 11. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG.
    J Urol; 2007 Nov 15; 178(5):1896-900. PubMed ID: 17868729
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G, Elie C, Conquy S, Vieillefond A, Flam T, Zerbib M, Debré B, Amsellem-Ouazana D.
    Urology; 2007 Feb 15; 69(2):230-5. PubMed ID: 17275070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
    Nakayama K, Tannir NM, Liu P, Wathen JK, Cheng YC, Champlin RE, Ueno NT.
    Biol Blood Marrow Transplant; 2007 Aug 15; 13(8):975-85. PubMed ID: 17640602
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
    Rodriguez GC, Clarke-Pearson DL, Soper JT, Berchuck A, Synan I, Dodge RK.
    Obstet Gynecol; 1994 Mar 15; 83(3):445-8. PubMed ID: 8127540
    [Abstract] [Full Text] [Related]

  • 18. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.
    Brockmann MA, Giese A, Mueller K, Kaba FJ, Lohr F, Weiss C, Gottschalk S, Nolte I, Leppert J, Tuettenberg J, Groden C.
    Neuro Oncol; 2007 Jul 15; 9(3):335-42. PubMed ID: 17504931
    [Abstract] [Full Text] [Related]

  • 19. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY.
    BJU Int; 2008 Mar 15; 101(6):758-64. PubMed ID: 18070177
    [Abstract] [Full Text] [Related]

  • 20. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
    Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, Takeda A, Gunji Y, Ochiai T.
    J Am Coll Surg; 2004 May 15; 198(5):737-41. PubMed ID: 15110807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.